UNIVERSITY OF SOUTHERN CALIFORNIA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1880-01-01

Employees: 10K

Market Cap: -

Website: http://startusc.com

Clinical Trials

Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects

Phase 2

Completed

Conditions: Dystonia

First Posted Date: 2005-07-21

Last Posted Date: 2014-05-23

Lead Sponsor: University of Southern California

Target Recruit Count: 35

Registration Number: NCT00122044

Locations: 🇺🇸
Rehabilitation Institute of Chicago, Chicago, Illinois, United States
🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
🇺🇸
Kennedy Krieger Institute, Baltimore, Maryland, United States

and more 4 locations

Women's Isoflavone Soy Health (WISH) Trial

Phase 2

Completed

Conditions: Atherosclerosis

Interventions: Dietary Supplement: 25 gm soy protein supplement
Other: Placebo

First Posted Date: 2005-07-12

Last Posted Date: 2023-05-06

Lead Sponsor: University of Southern California

Target Recruit Count: 350

Registration Number: NCT00118846

Locations: 🇺🇸
Atherosclerosis Research Unit, University of Southern California, Los Angeles, California, United States

ELITE: Early Versus Late Intervention Trial With Estradiol

Phase 2

Completed

Conditions: Atherosclerosis

Interventions: Drug: 17B-estradiol
Other: Placebo

First Posted Date: 2005-06-16

Last Posted Date: 2023-01-18

Lead Sponsor: University of Southern California

Target Recruit Count: 643

Registration Number: NCT00114517

Locations: 🇺🇸
Atherosclerosis Research Unit, University of Southern California, Los Angeles, California, United States

Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma

Phase 2

Completed

Conditions: Intraocular Melanoma
Melanoma (Skin)

First Posted Date: 2004-09-13

Last Posted Date: 2014-05-22

Lead Sponsor: University of Southern California

Target Recruit Count: 48

Registration Number: NCT00003339

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸
Beckman Research Institute, City of Hope, Duarte, California, United States

Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas

Phase 2

Completed

Conditions: Pancreatic Cancer

First Posted Date: 2004-08-12

Last Posted Date: 2014-05-22

Lead Sponsor: University of Southern California

Target Recruit Count: 21

Registration Number: NCT00002955

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

First Posted Date: 2004-07-30

Last Posted Date: 2014-05-22

Lead Sponsor: University of Southern California

Target Recruit Count: 46

Registration Number: NCT00003050

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸
Mayo Clinic Jacksonville, Jacksonville, Florida, United States

Cryosurgery in Treating Patients With Soft Tissue Sarcoma

Phase 1

Terminated

Conditions: Sarcoma

First Posted Date: 2004-07-07

Last Posted Date: 2014-05-22

Lead Sponsor: University of Southern California

Target Recruit Count: 19

Registration Number: NCT00002863

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer

Phase 1

Terminated

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2004-06-16

Last Posted Date: 2014-05-22

Lead Sponsor: University of Southern California

Target Recruit Count: 16

Registration Number: NCT00003009

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer

Phase 2

Terminated

Conditions: Pancreatic Cancer

First Posted Date: 2004-06-16

Last Posted Date: 2014-05-22

Lead Sponsor: University of Southern California

Target Recruit Count: 28

Registration Number: NCT00003085

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma

Phase 2

Completed

Conditions: Recurrent Intraocular Melanoma
Recurrent Melanoma
Stage IIIC Melanoma
Ciliary Body and Choroid Melanoma, Small Size
Stage IIIA Melanoma
Stage IIIB Intraocular Melanoma
Extraocular Extension Melanoma
Iris Melanoma
Ciliary Body and Choroid Melanoma, Medium/Large Size
Stage IIIB Melanoma

Interventions: Biological: gp100 antigen
Biological: tyrosinase peptide
Biological: recombinant MAGE-3.1 antigen
Biological: multi-epitope melanoma peptide vaccine
Biological: incomplete Freund's adjuvant
Drug: Montanide ISA 51 VG
Drug: agatolimod sodium
Other: laboratory biomarker analysis

First Posted Date: 2004-06-11

Last Posted Date: 2014-05-22

Lead Sponsor: University of Southern California

Target Recruit Count: 42

Registration Number: NCT00085189

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy